Position in LLY
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$109,364,036
+$22,715,265 QoQ
Shares Held
91,180
-3.2% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
1.12%
of 13F equity value
Holder Rank
#365
of 4,601 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026State of Alaska, Department of Revenue holds $360,428,859 across 10 Drug Manufacturers - General names. LLY ranks #1 (30.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
91,180 | $109,364,036 | |
| 2 | JNJ |
Johnson & Johnson
|
298,749 | $75,873,283 | |
| 3 | ABBV |
AbbVie Inc.
|
232,583 | $58,527,185 | |
| 4 | MRK |
Merck & Co., Inc.
|
299,881 | $38,534,708 | |
| 5 | AMGN |
Amgen Inc
|
62,806 | $22,743,307 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
155,936 | $19,700,953 | |
| 7 | PFE |
Pfizer Inc
|
676,905 | $16,299,872 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
252,254 | $14,534,874 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $109,364,036 | 91,180 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $86,648,771 | 94,207 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $100,973,717 | 93,957 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $76,385,456 | 100,112 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $72,161,870 | 92,571 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $79,567,343 | 96,339 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $72,528,628 | 93,949 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $87,800,196 | 99,104 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $89,944,069 | 99,344 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $81,665,572 | 104,974 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $63,756,290 | 109,374 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $62,502,594 | 116,364 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $55,890,221 | 119,174 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $48,532,457 | 141,321 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $52,280,730 | 142,906 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $46,115,852 | 142,619 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $48,781,375 | 150,453 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $62,800,080 | 219,297 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $63,770,358 | 230,868 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $57,820,954 | 250,253 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $57,534,237 | 250,672 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $54,474,656 | 291,589 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $52,527,473 | 311,108 | Shares | Sole | 2021-01-08 | |
| 2020-09-30 | $48,331,933 | 326,523 | Shares | Sole | 2020-10-05 | |
| 2020-06-30 | $32,120,831 | 195,644 | Shares | Sole | 2020-07-06 | |
| 2020-03-31 | $22,582,922 | 162,795 | Shares | Sole | 2020-04-06 | |
| No filing history on record for this holder in this stock. | ||||||